Authors
Venkata-Viswanadh Edara, Benjamin A Pinsky, Mehul S Suthar, Lilin Lai, Meredith E Davis-Gardner, Katharine Floyd, Maria W Flowers, Jens Wrammert, Laila Hussaini, Caroline Rose Ciric, Sarah Bechnak, Kathy Stephens, Barney S Graham, Elham Bayat Mokhtari, Prakriti Mudvari, Eli Boritz, Adrian Creanga, Amarendra Pegu, Alexandrine Derrien-Colemyn, Amy R Henry, Matthew Gagne, Daniel C Douek, Malaya K Sahoo, Mamdouh Sibai, Daniel Solis, Richard J Webby, Trushar Jeevan, Thomas P Fabrizio
Publication date
2021/8/12
Journal
New England Journal of Medicine
Volume
385
Issue
7
Pages
664-666
Publisher
Massachusetts Medical Society
Description
Neutralizing Activity against SARS-CoV-2 Variants
Among samples obtained from persons who had received the mRNA-1273 or BNT162b2 vaccines, neutralizing antibody titers against the B.1.617.1 variant were 6.8 times lower than those against the WA1/2020 variant, and titers against the B.1.617.2 variant were 2.9 times lower than those against WA1/2020.
Scholar articles
VV Edara, BA Pinsky, MS Suthar, L Lai… - New England Journal of Medicine, 2021